Wolverine Trading
FLNA

Wolverine Trading’s Filana Therapeutics FLNA Stock Holding History

Wolverine Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,000
Closed -$47.3K – 6105
2025
Q2 		$47.3K Sell
27,000
-1,700
-6% -$3.02K ﹤0.01% 4359
2025
Q1 		$47.4K Sell
28,700
-39,100
-58% -$98.7K ﹤0.01% 4438
2024
Q4 		$163K Sell
67,800
-69,200
-51% -$1.22M ﹤0.01% 4639
2024
Q3 		$3.9M Buy
137,000
+103,000
+303% +$2.37M ﹤0.01% 1211
2024
Q2 		$420K Buy
34,000
+7,000
+26% +$148K ﹤0.01% 3017
2024
Q1 		$548K Buy
+27,000
New +$622K ﹤0.01% 2742
2023
Q4 		– Sell
-59,200
Closed -$985K – 5125
2023
Q3 		$985K Buy
59,200
+13,300
+29% +$264K ﹤0.01% 2120
2023
Q2 		$1.09M Buy
45,900
+7,700
+20% +$185K ﹤0.01% 1943
2023
Q1 		$917K Sell
38,200
-6,100
-14% -$169K ﹤0.01% 1966
2022
Q4 		$1.31M Buy
+44,300
New +$1.59M ﹤0.01% 1654
2022
Q3 		– Sell
-62,400
Closed -$1.86M – 5234
2022
Q2 		$1.86M Sell
62,400
-3,200
-5% -$80.8K ﹤0.01% 1436
2022
Q1 		$2.53M Sell
65,600
-12,800
-16% -$542K ﹤0.01% 1559
2021
Q4 		$3.43M Sell
78,400
-59,200
-43% -$3.1M ﹤0.01% 1406
2021
Q3 		$8.55M Buy
137,600
+84,900
+161% +$7.09M 0.01% 907
2021
Q2 		$4.37M Buy
52,700
+5,000
+10% +$268K 0.01% 1269
2021
Q1 		$2.1M Buy
+47,700
New +$1.88M ﹤0.01% 1892
2016
Q3 		– Sell
-1,886
Closed -$28K – 5046
2016
Q2 		$28K Buy
+1,886
New +$29.9K ﹤0.01% 3876

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Wolverine Trading's FLNA Position: Q3 2024 in Review

Wolverine Trading sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 18,733 shares — an estimated $431K sold.

Wolverine Trading first reported a position in FLNA in Q3 2016 and held it in 9 quarters. The position peaked at $2.03M in Q3 2021. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Wolverine Trading reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 18,733 Filana Therapeutics shares in Q3 2024, an estimated $431K.
  • Wolverine Trading first reported a position in Filana Therapeutics in Q3 2016 and held it in 9 quarters.
  • Wolverine Trading's Filana Therapeutics position peaked at $2.03M in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.